Boston University Pushes Back on Claims of New COVID Strain – COVID Strain – Boston University laboratory denied the claim that they created a deadly new strain of COVID-19 with an 80% kill rate. The headlines were created by a British tabloid and picked up my many national US media outlets. However, the allegations are simply not true. This was clarified not only by the Boston University researchers who were accused, but also by third party experts. COVID-19 is a serious pandemic and it is crucial that information is spread accurately to prevent more panic and misinformation from spreading.
Researchers at Boston University’s National Emerging Infectious Diseases Laboratories (NEIDL) have been working on COVID-19 research since 2020, when the first COVID case was recorded in Washington state. They are trying to determine why the Omicron variant of COVID-19 causes less severe disease, and to find out what component of the virus determines its severity. In this 2022 study, they will be looking at the different strains of COVID-19 to see if there are any differences in how they affect people. by understanding how COVID-19 works, they hope to be able to create better treatments and eventually a prevention for the disease. Even though there is still a lot unknown about COVID-19, research like this is important in order to help control the spread of the disease and save lives.
COVID, also known as COVID-19, is a novel coronavirus that first appeared in 2019. Since then, it has spread rapidly throughout the world, causing a global pandemic. COVID is highly contagious and can cause severe illness, particularly in older adults and those with underlying medical conditions. There are currently no vaccines or treatments available for COVID. However, researchers are working hard to develop both. In order to do so, they need to understand the different strains of the virus and how they interact with each other. Recently, there has been much misinformation about a “new strain” of COVID. However, this is not accurate. What has happened is that researchers have compared the original COVID strain with a new strain, called Omicron. They have also created a version of the two strains combined. This research is essential in order to develop effective vaccines and treatments for COVID. Without it, the fight against this virus will be much more difficult.
Recently, there has been much controversy over a COVID strain that was found in Boston. Many people are concerned about the implications of this new strain and what it could mean for the future. However, experts say that this is standard protocol and nothing to be worried about. Dr. Daniel Kuritzkes, the Head of Infectious Disease at Brigham and Women’s Hospital, explained that this is the type of work that needs to be done in order to find vaccines and tests for COVID. Dr. Arthur Caplan, the Director of Medical Ethics at New York University’s Grossman School of Medicine, echoed this sentiment, saying that this is standard procedure and nothing out of the ordinary. With the help of experts like these, we can all rest assured that the COVID strain in Boston is nothing to be worried about.
COVID-19 has been a global pandemic for almost a year now. In that time, researchers have been working tirelessly to learn more about the virus in order to develop better treatments and vaccines. Recently, a team of researchers at Boston University developed a new strain of COVID-19, which they nicknamed “Omicron.” This new strain is more deadly than the original COVID-19 virus, but less deadly than the combined COVID-19/SARS-CoV-2 virus. In order to test the deadly potential of this new virus, the researchers injected large amounts of it into mice. 100% of the mice injected with the original COVID-19 virus died, while none of the mice injected with Omicron died. However, approximately 80% of the mice injected with the combined COVID-19/SARS-CoV-2 virus died. These results show that the new Omicron strain is more deadly than the original COVID-19 virus, but less deadly than the combined COVID-19/SARS-CoV-2 virus. This research will be critical in helping to develop better treatments and vaccines for COVID-19.
There has been a great deal of misinformation circulating about the COVID strain of the coronavirus. In particular, reports have surfaced about an alleged “80% kill rate” for this strain. However, these reports are based on data from animal models, which does not necessarily translate to humans. As Dr. Ronald B. Corley, director of the NEIDL lab, points out, these reports are false and inaccurate. He urges people to be careful about believing everything they read, especially when it comes to such a serious topic. With so much conflicting information out there, it’s important to be discerning about what you choose to believe.
As the COVID-19 pandemic continues to ravage communities across the globe, scientists are working tirelessly to develop a vaccine that can help to prevent the spread of the disease. However, some initial reports have raised concerns about the safety of this research, claiming that the virus could leak out of the lab and cause a new outbreak. However, Dr. Daniel Kuritzkes, an infectious disease specialist at Boston University School of Medicine, is quick to dispel these fears. “There is no risk to doing these experiments in the city of Boston because these are being done under the highest level of containment to ensure that there is no release of any materials at all from the lab into the environment,” he explains. Likewise, Dr. Arthur Caplan, head of medical ethics at NYU Langone Health, adds that “[in the US,] we are much more careful, much more cautious than basically anywhere else in the world about this kind of work.” It is important to note that the work being performed in Boston has been approved by Boston University, a biosafety review committee, and the Boston Public Health Commission. With such strict safety protocols in place, there is no need to fear that the COVID-19 virus will escape from the lab and cause another outbreak.
The new COVID strain, first identified in the United Kingdom, has been found in the United States. The findings were published in a research paper by Boston University (BU) researchers. The new variant is called B.1.1.7 and is said to be more contagious than the original COVID-19 virus. The study has not yet been peer-reviewed. There is one controversy surrounding the fallout from these reports. Representatives from the National Institute of Allergy and Infectious Diseases, or NIAID, said they wished BU had told them the research it was working on. But according to a BU spokesperson, the researchers didn’t have to. “We fulfilled all required regulatory obligations and protocols. Following NIAID’s guidelines and protocols, we did not have an obligation to disclose this research for two reasons. The experiments reported in this manuscript were carried out with funds from Boston University. NIAID funding was acknowledged because it was used to help develop the tools and platforms that were used in this research; they did not fund this research directly,” the university said. As of now, there are no plans to halt flights from the UK to the US amid this new development. However, health officials are urging people to get tested and to practice safety measures such as wearing a mask and social distancing.
For more details please click here.